XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
Long-Term Investments (Details) - Schedule of extent the investee relies
9 Months Ended
Sep. 30, 2022
Braingenesis Biotechnology Co., Ltd. [Member]  
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]  
Relationship with the Company and its subsidiaries, description No specific business relationship
Genepharm Biotech Corporation [Member]  
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]  
Relationship with the Company and its subsidiaries, description No specific business relationship
BioHopeKing Corporation [Member]  
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]  
Relationship with the Company and its subsidiaries, description Collaborating with the Company to develop and commercialize drugs
BioFirst Corporation [Member]  
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]  
Relationship with the Company and its subsidiaries, description Collaborating with the Company to develop and commercialize drugs
Rgene Corporation [Member]  
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]  
Relationship with the Company and its subsidiaries, description Collaborating with the Company to develop and commercialize drugs